Valeant Pharmaceuticals reported $-595000000 in Net Income for its second fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Net Income Change
Amgen AMGN:US $ 464M 1182M
Ani Pharmaceuticals ANIP:US $ -14.11M 14.19M
Aphria Inc APH:CN C$ -360996000 240.4M
Aurora Cannabis Inc ACB:CN -128125000 36.52M
Biogen BIIB:US $ 329.2M 119.3M
Bristol Myers Squibb BMY:US $ 1055M 966M
Canopy Growth Corp WEED:CN C$ 392.42M 1.09B
Catalent CTLT:US $ 182.4M 49.4M
Corcept Therapeutics CORT:US $ 26.52M 3.06M
Danaher DHR:US $ 1158M 627M
Drreddys Laboratories RDY:US $ 5708M 2084M
Eli Lilly And LLY:US $ 1110.1M 280.1M
Endo International Ordinary Shares ENDP:US $ -15.5M 57.02M
Gilead Sciences GILD:US $ 1522M 207M
Gw Pharmaceuticals GWPH:US $ -19.68M 9.47M
Horizon Pharma HZNP:US $ 158.12M 281.47M
JAZZ PHA JAZZ:US $ -363.32M 485.15M
Lannett LCI:US $ -177.89M 170.74M
Nektar Therapeutics NKTR:US $ -125.52M 2.55M
Pacira Pharmaceuticals PCRX:US $ 19.08M 8.71M
Perrigo Ordinary Shares PRGO:US $ -57.7M 95.8M
Phibro Animal Health PAHC:US $ 17.12M 4.96M
Prestige Brands PBH:US $ 57.76M 22.24M
Revance Therapeutics RVNC:US $ -72.2M 0.56M
Supernus Pharmaceuticals SUPN:US $ 23.73M 18.03M
Valeant Pharmaceuticals VRX:CN $ -595M 15M
Vertex Pharmaceuticals VRTX:US $ 66.92M 586.21M
Zoetis ZTS:US $ 512M 47M